```html

Hematemesis: What It Is, Why It Happens, and How to Manage It

Overview

Hematemesis is the medical term for vomiting blood. The blood may appear as bright red, “coffee‑ground” (dark, granular) material, or mixed with partially digested food. Hematemesis signals bleeding somewhere in the upper gastrointestinal (GI) tract—typically the esophagus, stomach, or the first part of the small intestine (duodenum).

Although anyone can develop hematemesis, it is most common in:

• Adults > 50 years old (especially men)
• People with chronic alcohol use, liver disease, or peptic ulcer disease
• Patients taking non‑steroidal anti‑inflammatory drugs (NSAIDs) or anticoagulants

In the United States, upper‑GI bleeding accounts for roughly 1–2 % of emergency department visits each year, and hematemesis is present in about 50 % of those cases. Worldwide, the incidence varies widely—estimated at 50–150 cases per 100,000 people annually, with higher rates in regions with prevalent Helicobacter pylori infection and limited access to endoscopy.<sup>[1] WHO Global Health Estimates, 2023</sup>

Symptoms

Bleeding in the upper GI tract can produce a spectrum of signs, ranging from subtle to life‑threatening. Common symptoms include:

• Vomiting of bright red blood – indicates rapid, active bleeding.
• Coffee‑ground emesis – dark, granular material when blood has been partially digested; suggests slower or older bleeding.
• Melena – black, tarry stools caused by digested blood (often accompanies hematemesis).
• Abdominal or epigastric pain – may point to a peptic ulcer or gastritis.
• Nausea & vomiting – sometimes without blood initially.
• Dizziness, light‑headedness, or syncope – signs of significant blood loss.
• Fatigue, weakness, or pallor – due to anemia.
• Rapid heart rate (tachycardia) and low blood pressure (hypotension) – indicate hemorrhagic shock.
• Fever or chills – may suggest an infectious cause (e.g., variceal bleed with bacterial translocation).

Because blood loss can be hidden (especially in early or low‑volume bleeds), patients should report any sudden change in stool color, unexplained weakness, or feeling “unwell” after a heavy stomach upset.

Causes and Risk Factors

Hematemesis results when a lesion erodes into a blood vessel in the upper GI tract. The most frequent causes are:

1. Peptic ulcer disease (PUD)

Ulcers in the stomach or duodenum break through the mucosa, exposing arterial vessels. Mayo Clinic estimates that up to 10 % of ulcer patients experience bleeding.

2. Esophageal varices

Portal hypertension (often due to cirrhosis) dilates veins in the lower esophagus. These veins can rupture under pressure, leading to massive hematemesis. Variceal bleeding accounts for 30–40 % of upper‑GI bleeds in cirrhotic patients.<sup>[2] NIH Liver Disease Fact Sheet, 2022</sup>

3. Gastritis & erosive disease

Inflammation from NSAIDs, alcohol, or H. pylori can cause superficial erosions that bleed.

4. Mallory‑Weiss tear

A longitudinal mucosal laceration at the gastro‑esophageal junction caused by forceful vomiting or retching. More common in young adults with binge‑eating or alcohol intoxication.

5. Malignancy

Gastric or esophageal cancer can ulcerate and erode vessels. Although less common, it should be considered in persistent or recurrent bleeding.

6. Rare causes

• Dieulafoy lesion (an aberrant submucosal artery)
• Aorto‑enteric fistula (usually following aortic surgery)
• Coagulopathies (e.g., severe vitamin K deficiency, thrombocytopenia)

Key Risk Factors

• Chronic alcohol use
• Advanced liver disease / cirrhosis
• Regular NSAID or aspirin use
• H. pylori infection
• Smoking
• Older age (vascular fragility)
• Anticoagulant or antiplatelet therapy (warfarin, DOACs, clopidogrel)
• Severe stress (e.g., major surgery, burns) – “stress‑related gastritis”

Diagnosis

Prompt evaluation is essential because bleeding can progress quickly. The diagnostic approach combines clinical assessment with targeted investigations.

Initial Clinical Assessment

• Vital signs – heart rate, blood pressure, O₂ saturation.
• Physical exam – abdominal tenderness, signs of chronic liver disease, orthostatic changes.
• History – timing, amount and appearance of blood, medication use, alcohol intake, previous GI disease.

Laboratory Tests

• Complete blood count (CBC) – assesses hemoglobin/hematocrit for anemia.
• Basic metabolic panel – evaluates electrolytes and renal function (important before contrast imaging).
• Coagulation profile (PT/INR, aPTT) – crucial if the patient is on anticoagulants or has liver disease.
• Blood type & cross‑match – prepare for possible transfusion.
• Serum lipase/amylase – to rule out pancreatitis if pain is significant.

Imaging & Endoscopic Studies

1. Upper endoscopy (esophagogastroduodenoscopy, EGD) – the gold standard. Allows direct visualization, classification of the lesion, and therapeutic intervention (e.g., banding, clipping). Recommended within 24 hours for most patients, and within 12 hours for those with hemodynamic instability.<sup>[3] American College of Gastroenterology Guidelines, 2022</sup>
2. Contrast‑enhanced CT angiography – useful when endoscopy is unavailable or if bleeding is massive and ongoing; can locate active extravasation.
3. Radionuclide (Technetium‑99m) bleeding scan – detects slow bleeding (<0.5 mL/min) but less precise for localization.
4. Abdominal ultrasound – primarily to assess liver disease and portal hypertension.

Risk Stratification Tools

Scales like the Rockall score or Blatchford score help predict the need for intervention and hospital admission.

Treatment Options

Treatment is aimed at stopping the bleed, correcting the underlying cause, and preventing recurrence.

Initial Stabilization (First 60 minutes)

• Airway protection – place the patient in a semi‑recumbent position; consider endotracheal intubation if massive bleeding or altered mental status.
• IV fluid resuscitation – isotonic crystalloids (e.g., normal saline) in 1‑2 L boluses, guided by blood pressure and urine output.
• Blood transfusion – target hemoglobin >7 g/dL in stable patients; higher thresholds (>8–9 g/dL) for those with cardiovascular disease or ongoing bleeding.
• Proton‑pump inhibitor (PPI) therapy – IV pantoprazole 80 mg bolus then 8 mg/hr infusion reduces gastric acid, stabilizes clots, and improves endoscopic outcomes.<sup>[4] Cleveland Clinic</sup>
• Octreotide (somatostatin analogue) – 50 µg IV bolus followed by 50 µg/hr infusion if variceal bleeding is suspected; decreases portal pressure.

Definitive Endoscopic Therapy

• Peptic ulcer bleed – epinephrine injection + thermal coagulation or hemostatic clips.
• Esophageal varices – rubber band ligation (most effective) or sclerotherapy.
• Mallory‑Weiss tear – usually self‑limited; endoscopic clipping if active bleeding.
• Dieulafoy lesion – mechanical clipping or thermal coagulation.

Radiologic & Surgical Interventions

• Trans‑arterial embolization (TAE) – performed by interventional radiology when endoscopic control fails.
• Surgical resection or oversewing – reserved for uncontrolled hemorrhage or perforated ulcers.

Medications for Underlying Conditions

• H. pylori eradication (triple or quadruple therapy) after bleeding is controlled.
• Long‑term oral PPIs for ulcer prophylaxis, especially if NSAID use continues.
• Beta‑blockers (e.g., propranolol or carvedilol) to reduce portal pressure in cirrhotics.
• Discontinuation or dose reduction of NSAIDs, aspirin, and anticoagulants when safe.

Lifestyle & Supportive Measures

• Alcohol cessation – reduces variceal pressure and ulcer risk.
• Smoking cessation – improves mucosal healing.
• Nutrition: small, frequent, low‑acid meals; avoid spicy or fried foods during recovery.

Living with Hematemesis

Even after the acute episode resolves, many patients require ongoing management to prevent recurrence.

• Medication adherence: Take PPIs or H₂‑blockers exactly as prescribed. Use a pill organizer or set daily alarms.
• Follow‑up endoscopy: Usually scheduled 4–8 weeks after a high‑risk ulcer to confirm healing.
• Regular lab monitoring: CBC and liver function tests every 3–6 months if you have cirrhosis or chronic anemia.
• Vaccinations: Hepatitis A & B for liver disease; influenza and COVID‑19 to avoid infections that could worsen portal hypertension.
• Alcohol and drug counseling: Seek community or tele‑health programs; many insurers cover brief interventions.
• Stress management: Mindfulness, yoga, or counseling can lower physiologic stress that aggravates gastritis.
• Emergency plan: Keep a written note of your diagnosis, current meds, and contact numbers for your gastroenterologist. Share this with family members.

Prevention

Targeted prevention reduces both the first and recurrent episodes of hematemesis.

1. Eradicate Helicobacter pylori if testing is positive – a 14‑day triple therapy regimen can cut ulcer recurrence by ~80 %.<sup>[5] WHO H. pylori Guidelines, 2022</sup>
2. Use NSAIDs cautiously – take the lowest effective dose, with food, and add a PPI if long‑term use is necessary.
3. Limit alcohol intake – no more than 2 standard drinks per day for men, 1 for women; seek treatment for dependence.
4. Manage liver disease – maintain weight, control diabetes, and adhere to antiviral therapy for hepatitis B/C.
5. Control blood pressure and diabetes – reduces risk of gastric mucosal injury.
6. Vaccinate against varicella‑zoster in high‑risk cirrhotics to lower the chance of variceal bleeding from viral reactivation.
7. Regular screening endoscopy for patients with known Barrett’s esophagus, large varices, or prior ulcer bleeding.

Complications

If bleeding is not controlled promptly, serious complications may develop:

• Hypovolemic shock – life‑threatening low blood volume leading to organ failure.
• Severe anemia – causing fatigue, chest pain, or cardiac ischemia.
• Acute kidney injury – from hypoperfusion.
• Aspiration pneumonia – if vomitus enters the lungs.
• Esophageal stricture – scarring after repeated ulceration or banding.
• Re‑bleeding – occurs in 10–20 % of ulcer patients within 30 days if risk factors persist.
• Portal hypertensive gastropathy – chronic bleeding source in cirrhosis patients.

When to Seek Emergency Care

References

1. World Health Organization. Global Health Estimates 2023. https://www.who.int/data/gho
2. National Institutes of Health. Liver Disease Fact Sheet. 2022. https://www.nih.gov/liver-disease
3. American College of Gastroenterology. Guidelines for Management of Acute Upper GI Bleeding. 2022. https://gi.org/guidelines/acute-gi-bleeding
4. Cleveland Clinic. Proton Pump Inhibitor Therapy for Upper GI Bleeding. 2023. https://my.clevelandclinic.org/health/articles/17821-proton-pump-inhibitors
5. World Health Organization. Helicobacter pylori Management Guidelines. 2022. https://www.who.int/publications/i/item/WHO-2022-HPylori

```